FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Panel Votes to Support Paxlovid NDA Approval

An FDA Advisory Committee votes 16 to 1 that Pfizers Paxlovid (nirmatrelvir and ritonavir) has a favorable benefit-risk profile for treating mild-to-m...

latest-news-card-1
Human Drugs

Community Should Push AA Drug Studies: Califf

FDA commissioner Robert Califf calls on health insurers to play a role in seeing that confirmatory trials are completed for drugs approved through the...

latest-news-card-1

Clinical Investigation Electronic Systems Guidance

FDA publishes a draft guidance on using electronic systems, records, and signatures in clinical investigations of some regulated products.

latest-news-card-1
Human Drugs

FDA Modifies Partial Hold on Davet Syndrome Drug

FDA modifies a partial clinical hold against Stoke Therapeutics to allow the administration of a higher single dose of STK-001 (70 mg) in its ongoing ...

latest-news-card-1
Federal Register

Info Collection on Radioactive Drug Research

Federal Register notice: FDA seeks comments on an information collection extension entitled Radioactive Drug Research Committees 21 CFR 361.1.

latest-news-card-1
Federal Register

6 No-Longer-Marketed ANDAs Withdrawn

Federal Register notice: FDA withdraws approval of six ANDAs from multiple applicants after they notified the agency that the products are no longer m...

latest-news-card-1
Human Drugs

Bill to Streamline Generic Drug Approvals

Sens. Paul and Hassan reintroduce their bill to require FDA to more clearly identify differences between generic drugs that have been submitted for ap...

latest-news-card-1
Human Drugs

Former Drug Sales Rep Pleads Guilty

The Department of Justice says former drug sales representative Vincent Tornari pled guilty to one count of healthcare fraud and wire fraud involving ...

latest-news-card-1
Human Drugs

FDA Reviewers Seem Positive on Paxlovid NDA

An FDA advisory committee briefing document says data support the efficacy of Pfizers Paxlovid (nirmatrelvir and ritonavir) for treating mild-to-moder...

latest-news-card-1

Mixed Stakeholder Views on Orange Book Listings

The Government Accountability Office says 15 stakeholders had widely varying views on the listing of drug/device combination product patents in the FD...